Why the study?
Does cardiac resynchronization therapy improve neurohumoral indices in patients with heart failure and LVEF <35%?
Population
13 patients with heart failure and left ventricular ejection fraction <35%
Comparison
Cardiac resynchronization therapy for 6 months vs Baseline (before CRT)
Design
Case_series
Follow-up
6 months
Authors
Loading...
CRT may improve neurohumoral markers in HF; single case report leaves open confirmation in controlled trials.
Does cardiac resynchronization therapy improve neurohumoral indices in patients with heart failure and LVEF <35%?
Cardiac resynchronization therapy induces favorable neurohumoral changes, including improved sympathetic nerve function and reduced BNP, alongside reverse remodeling in heart failure patients.
Erol-Yilmaz et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: